Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

COVID-19 can cause skin issues like hives, rashes, and chickenpox-like eruptions, with women aged 31-40 being the most affected.

Understanding drug effects and careful monitoring are crucial for safe and effective dermatology treatments.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

Skin problems are very common in people with end-stage kidney disease.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

COVID-19 may cause hair loss due to infection stress or treatments.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

The COVID-19 pandemic led to fewer dermatology visits, older and more male patients, and more stress-related skin issues.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

Vitamin D is crucial for skin health and managing skin diseases.

The document covers various dermatological conditions and their studies.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Eleven traditional Polynesian plants show potential for natural anti-aging, hair growth, and skin brightening products.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

Alopecia greatly affects Greek women's daily life, relationships, and self-image, with mixed social support and dissatisfaction with treatments.